Post‐treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation
Matthew D. Wood, Tanaya Neff, Joshua P. Nickerson, Christina M. Sayama, Ahmed M. Raslan, Prakash Ambady, Christopher L. Corless, Kellie J. Nazemi
Abstract
The authors declare that they have no competing interests. The peer review history for this article is available at https://publons.com/publon/10.1111/nan.12679. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
Somatic hypermutationMutationGliomaContent (measure theory)GeneticsComputer scienceCancer researchBiologyGeneMathematicsB cellMathematical analysisAntibodyGlioma Diagnosis and TreatmentDrug Transport and Resistance MechanismsCancer Genomics and Diagnostics